Cellebrite DI (CLBT) Cost of Revenue (2020 - 2025)
Historic Cost of Revenue for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $38.6 million.
- Cellebrite DI's Cost of Revenue rose 854.91% to $38.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $154.8 million, marking a year-over-year increase of 1693.87%. This contributed to the annual value of $154.8 million for FY2025, which is 1693.87% up from last year.
- Per Cellebrite DI's latest filing, its Cost of Revenue stood at $38.6 million for Q4 2025, which was up 854.91% from $38.8 million recorded in Q3 2025.
- Cellebrite DI's 5-year Cost of Revenue high stood at $38.8 million for Q3 2025, and its period low was $16.5 million during Q1 2021.
- In the last 5 years, Cellebrite DI's Cost of Revenue had a median value of $27.2 million in 2023 and averaged $28.6 million.
- Per our database at Business Quant, Cellebrite DI's Cost of Revenue skyrocketed by 4081.0% in 2022 and then skyrocketed by 510.81% in 2023.
- Cellebrite DI's Cost of Revenue (Quarter) stood at $21.2 million in 2021, then rose by 11.44% to $23.7 million in 2022, then increased by 25.03% to $29.6 million in 2023, then grew by 20.04% to $35.5 million in 2024, then rose by 8.55% to $38.6 million in 2025.
- Its Cost of Revenue was $38.6 million in Q4 2025, compared to $38.8 million in Q3 2025 and $38.7 million in Q2 2025.